Life stress is a major risk factor in the onset and exacerbation of mast cell-associated diseases, including allergy/anaphylaxis, asthma, and irritable bowel syndrome. Although it is known that mast cells are highly activated upon stressful events, the mechanisms by which stress modulates mast cell function and disease pathophysiology remains poorly understood. Here, we investigated the role of corticotropin-releasing factor receptor subtype 1 (CRF 1 ) in mast cell degranulation and associated disease pathophysiology. In a mast celldependent model of IgE-mediated passive systemic anaphylaxis (PSA), prophylactic administration of the CRF 1 -antagonist antalarmin attenuated mast cell degranulation and hypothermia. Mast cell-deficient Kit 
Introduction
MCs are innate immune cells well-known for their critical roles in health and survival, including pathogen defense, immune modulation, and tissue repair. As sentinel cells, MCs are strategically positioned at environmental host interfaces, such as epithelial barriers in the gut, skin, respiratory tract, and bladder, are located in close proximity to blood vessel endothelium and neurons and express receptors for a wide array of Ags, pathogens, cytokines, and neuropeptides, among others. Furthermore, MCs synthesize and store potent mediators, including histamine, proteases, and cytokines within cytoplasmic granules, which are released immediately upon stimuli-induced degranulation. Together, these unique properties of MCs provide a mechanism to sense environmental and host stress cues and to generate a rapid and robust response required for survival and for return to homeostasis. However, excessive MC degranulation is central to the pathogenesis of a number of stress-related MC diseases, including allergy/anaphylaxis, asthma, and functional and inflammatory GI disorders [1] [2] [3] [4] , but the mechanisms driving MC hyperactivation in these diseases remain poorly defined.
A major risk factor in the onset of MC-associated disorders, including allergy, asthma, and IBS, is life stress [5] [6] [7] . Experimental studies in animal models and humans have reported a link between psychologic stressors and increased tissue MC activation and pathophysiology, including inflammation and intestinal permeability [8] [9] [10] [11] [12] [13] . Despite the established connection between stress and MC activation, precisely how stress modulates MC activation and its role in MC disease pathogenesis has remained elusive.
The CRF system, composed of CRF and related the family of Ucn (Ucn I-III) [14] , and their GPCRs, CRF 1 and CRF 2 [15] , are well-established as a major stress regulatory system in the body. Although most extensively studied in the context of psychosocial stress, HPA axis regulation, and neurobehavioral paradigms [14] , the CRF system has also been shown to be active in peripheral immunologic and infectious challenge conditions [16] [17] [18] [19] [20] , suggesting an important role for the CRF system in regulating a diverse array of stressful stimuli. Specifically, an extensive literature exists about the CRF system regulation of neuronal function, especially within the CNS; however, comparatively, there is little information about the role of the CRF system in regulating specific immune cells and immune-mediated pathophysiology in vivo. Human MCs express CRF 1 and CRF 2 [21] [22] [23] , which, upon activation with pharmacologic agonists, induce canonical GPCR signaling pathways and selective cytokine release in vitro [21, 22, 24] . However, the role that CRF receptors have in MC degranulation and the MC-associated diseases in vivo is unknown. The objective of the present studies was to investigate the role of CRF 1 receptor signaling in MC degranulation responses and in vivo pathophysiologic responses to immunologic and psychologic stressors.
MATERIALS AND METHODS

Animals
All protocols were approved by the Michigan State University Institutional Animal Care and Use Committee (protocol 03/15-039-00). Founding breeders for all mice strains were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and were housed in accordance with guidelines from the American Association for Laboratory Animal Science care and research protocols. C57BL/6 (stock 000664) and Kit W-sh/W-sh mice (stock 012861) used in this study were derived from homozygous breeders. Heterozygous CRF 1 +/2 mice (B6; 129-Crhr1 tm1Klee /J; stock 004454) were purchased and bred to obtain WT (CRF 1 +/+ ) and CRF 1 2/2 mice. The generation of CRF 1 -deficient mice has been described previously [25] . Genotyping of offspring was performed both in house and confirmed commercially (GeneTyper, New York, NY, USA) using PCR protocols published at http://www.jax.org.
PSA model
Mice were sensitized by i.p. injection with 20 mg of IgE monoclonal anti-DNP in 100 ml PBS. The following day, mice were challenged with 1 mg of DNP in 100 ml PBS (i.p.). For CRF 1 antagonist experiments, IgE-sensitized WT C57Bl/ 6 mice were administered the CRF 1 antagonist Antalarmin (Sigma-Aldrich, St. Louis, MO, USA) via the tail vein (15 mg/kg), 30 min before DNP-HSA challenge. Rectal temperatures were recorded at 0, 15, 30, 60, and 120 min after DNP challenge (TH-5 Thermalert; Physitemp, Clifton, NJ, USA). In indicated experiments, clinical symptoms were recorded every 10 min and were used to derive clinical scores using the anaphylactic symptom scoring system developed by Sun et al. [26] . Briefly, absence of clinical symptoms was given a score of 0; repetitive facial scratching, a score of 1; reduced activity and facial puffiness, a score of 2; periods of motionlessness for 1 min, a score of 3; and no movement to gentle prodding, a score of 4. Mice were euthanized 120 min after DNP injection, and serum was collected via cardiac puncture and stored at 280°C until serum histamine level was quantified using a commercial EIA kit (Oxford Biomedical Research, Rochester Hills, MI, USA). Tissue MC activation was assessed in mesenteric tissues collected from mice at 120 min after DNP challenge, and tissues were fixed in Carnoy's fixative and stained with toluidine blue to visualize the MCs and assess degranulation. 
BMMC engraftment in
Restraint stress model
Mice were placed in individual, transparent, 50-ml, plastic conical tubes, which were modified with air holes, for either 1 or 3 h, depending on the experiment. Control (nonstressed) mice remained in their original home cages for 3 h without food and water to avoid confounding effects of water or feed intake between stressed and unstressed animals. After RS, mice were immediately euthanized by CO 2 inhalation, and serum and ileal segments were collected for measurement of serum histamine and intestinal permeability, respectively, in Ussing chambers (Physiologic Instruments, San Diego, CA).
Ussing chamber experiments: TER and FD4 flux measurements ; pH 7.4) at 37°C, and then, mounted in a 0.3-cm 2 aperture in the Ussing chambers (Physiologic Instruments or World Precision Instruments, Sarasota, FL, USA), as described in previous studies [27, 28] . The tissue was bathed in rodent Ringer solution on each side of the tissue. The serosal bathing solution contained 10 mM glucose, which was balanced with 10 mM mannitol on the mucosal side. Bathing solutions were oxygenated (95% O 2 , 5% CO 2 ) and maintained at 37°C. The spontaneous potential difference was measured using Ringer-agar bridges connected to calomel electrodes, and the potential difference was short-circuited through Ag-AgCl electrodes using a voltage clamp that corrected for fluid resistance. Tissues were maintained in the short-circuited state, except for brief intervals, to record the open-circuit potential difference. TER (V cm 2 ) was calculated from the spontaneous potential difference and short-circuit current. After a 30-min equilibration period in Ussing chambers, TER was recorded at 5-min intervals for a 60-min period and then averaged to derive the basal TER values for a given animal.
After 30 min equilibration in Ussing chambers, FD4 (100 mg/ml; SigmaAldrich) was added to the mucosal bathing reservoir of the Ussing chambers.
After 15 min equilibration, standards were taken from the serosal side of each chamber, and a 60 min flux period was established by taking 0.5 ml samples from the mucosal compartment. The quantity of FD4 was established by measuring the fluorescence in mucosal reservoir fluid samples in a fluorescence plate reader at 540 nm. Data were presented as the rate of FD4 flux in nanogram of FD4 minutes per square centimeter.
Culture and activation of BMMCs, RBL-2H3 cells, and human LAD2 MCs Isolated bone marrow progenitor cells were cultured in RPMI 1640 media (with L-glutamine) supplemented with FBS (10%), sodium pyruvate (1 mM), MEM nonessential amino acids (13) , HEPES buffer (10 mM), penicillin (100 U/ml), and streptomycin (100 mg/ml) and with recombinant cytokines [stem cell factor (5 ng/ml) and IL-3 (5 ng/ml)]. After 4 wk, cultures were composed mainly of MCs (98%), as determined by toluidine blue (SigmaAldrich) staining, and flow cytometry analysis (LSR II; BD Biosciences, East Lansing, MI, USA) using fluorescently labeled c-Kit (BioLegend, San Diego, CA, USA) and high-affinity IgE receptor (FceRI) Abs (eBioscience, San Diego, CA, USA) Media and supplements were purchased from Corning Cellgro (Manassas, VA, USA), and recombinant cytokines were purchased from R&D Systems (Minneapolis, MN, USA). The rat basophilic leukemia cell MC line (RBL-2H3) was grown in MEM media with 10% FBS. Human LAD2 cells, a gift provided by Dr. A. Kirshenbaum (U.S. National Institutes of Health, Bethesda, MD, USA), were cultured in StemPro-34 media (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with StemPro-34 nutrient supplement (Thermo Fisher Scientific), L-glutamine (2 mM; Thermo Fisher Scientific), penicillin (100 U/ml), streptomycin (100 mg/ml), and recombinant human stem cell factor (100 ng/ml; PeproTech, Rocky Hill, NJ, USA). Cell density was kept below 0.5 3 10 6 cells/ml, and one-half of the media was replaced weekly.
CRF 1 overexpression and knockdown in RBL-2H3 MCs
LentiORF clone of CRF 1 (CRHR1), transcript variant 1 (OriGene, Rockville, MD, USA), CRF1 shRNA EGFP-tagged (MSH026851-LvU6; GeneCopoeia, Rockville, MD, USA) and control membrane GFP-tagged plasmid were obtained from OriGene (RC226816L2). DH5a-competent cells were obtained from Thermo Fisher Scientific (18265017). Plasmids were transfected and plated on selective antibiotic-resistance LB plates, according to the manufacturer's protocol. After overnight incubation at 37°C, a single colony was picked for each individual clone and inoculated on 2.5 ml LB medium containing antibiotics and kept for 8 h at 37°C at 200 rpm. A total of 600 ml of culture inoculum was transferred into 300 ml of LB broth on a sterile 1-L flask with antibiotics and kept at 200 rpm at 37°C overnight. Plasmid was extracted and the concentration was measured according to the manufacturer's protocol (12662; Qiagen, Germantown, MD, USA). Human embryonic kidney cell 293Ta lentivirus cells were seeded at a concentration of 1.5 3 10 6 cells per well (6 wells) and 2.5 mg of CRF 1 overexpressed or eGFP plasmid control DNA was transfected using a lentiviral packaging kit (OriGene) according to the manufacturer's protocol. After overnight incubation at 37°C with 5% CO 2 , the transfection medium was replaced with normal 5% DMEM media with polybrene (1 ml of 4 mg/ml); 48 h after transfection, the supernatant was collected from the 6-well plate and filtered onto a Nalgene ultracentrifuge tube (Nalge Nunc International, Rochester, NY, USA), and 5 ml of 20% sucrose was added into the bottom of the tube and centrifuged at 25,000 rpm for 2 h at 4°C. Then, the supernatant was discarded and the lentiviral overexpressing CRF 1 . The next day, cells were washed with Tyrode's buffer to remove excess IgE and challenged with streptavidin (500 ng/ml) for 7 min and centrifuged at 450 g for 5 min at 5°C, and 30 ml of supernatant was transferred into a new plate containing 10 ml of PNAG (p-nitrophenyl-N-acetyl-b-D-glucosaminide) (3.4 mg/ml in citrate buffer) and incubated for a further 90 min at 37°C. Excess cell supernatants were removed carefully, and cell pellets were lysed (0.1% Triton X-100 in Tyrode's buffer), and the residual b-hex was estimated in parallel. The reaction was stopped by adding 100 ml of 0.1 M carbonate/ bicarbonate buffer (pH 10) into each well. For A23187 and c48/80 stimulation, unsensitized BMMCs were stimulated for 1 h. b-activity was measured by addition of PNAG in 0.1 M sodium citrate (pH 4.5) for 1 h at 37°C. The reaction was terminated with 0.1 M carbonate buffer (pH 10.0), and the absorbance was recorded at 405 nm. The percentage of degranulation was calculated by dividing the optical absorbance of the supernatant by the sum of the optical absorbance by the supernatant and cell pellet (lysed with 0.1% Triton X-100) and multiplying by 100.
Histamine measurements in BMMC and RBL-2H3 cells
Histamine concentrations were quantified in cell pellets and supernatants from stimulated MC cultures with a histamine EIA kit (Oxford Biomedical Research).
Intracellular calcium measurements
RBL-2H3 cells and murine BMMCs derived from CRF 1 WT and CRF 1 2/2 mice were used for this study. On the day of the experiment, cells were washed and resuspended in calcium assay buffer. Changes in intracellular Ca 2+ in response to stimulus were detected using the Fluo 4 NW calcium assay kit (Thermo Fisher Scientific), according to manufacturer's instructions. Briefly, IgEsensitized MCs were loaded at a concentration of 5 3 10 4 (RBL-2H3) and 1 3 
RT-PCR
Total RNA was extracted from RBLs of transiently or permanently transfected cells along with respective controls and 6-10-wk-old BMMCs of CRF 1 WT and CRF 1 2/2 cells using Qiagen RNeasy minikit (Qiagen). One microgram of total RNA was used to synthesis the cDNA and amplified using the maxima first strand cDNA synthesis kit (Thermo Fisher Scientific). RT-PCR mix was prepared by using SYBR select master mix (Thermo Fisher Scientific) and real-time PCR was carried out in A&B Fast 7500 Biosystems (Thermo Fisher Scientific) with CRF 1 -specific primers (KSPQ12012; Sigma-Aldrich) and CRF 2 specific primers (KSPQ12012; Sigma-Aldrich). GAPDH forward 59-TGCACCA-CCAACTGCTTAG-39 and reverse 59-GGATGCAGGGATGATGTTC-39 was used as normalizing control. Immunofluorescent staining and confocal analysis RBL-2H3 cells were cultured in 8-well chamber slides (Thermo Fisher Scientific) and 6-8-wk-old WT BMMCs were pelleted, washed once with 13 PBS, cytospun onto slides, and fixed with 4% PFA for 20 min at 4°C. Slides were blocked at room temperature for 1 h with blocking buffer (10% normal donkey serum, 0.3% Triton X-100) in 13 PBS, and incubated with goat anti-CRF 1 antibody (0.3 mg/ml, ab77686; Abcam) in dilution buffer (1% BSA, 1% normal donkey serum, 0.3% Triton X-100, and 0.01% sodium azide in 13 PBS) for overnight at 4°C. Slides were washed 3 times for 5 min then incubated in anti-goat FITC (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) in dilution buffer (1:1000) for 1 h at room temperature in the dark. Slides were washed 3 times for 5 min with 13 PBS, and one drop of ProLong Diamond Antifade Mountant with DAPI (P36971; Thermo Fisher Scientific) was added with cover slips. Slides were dried at room temperature overnight and stored at 4°C until imaged. Confocal images were obtained with an FV 1000 confocal laser scanning microscope (Olympus America, Center Valley, PA, USA).
Protein extraction and Western blot analysis
cAMP assays in BMMCs
Six-week-old WT mice BMMCs were used for this assay (2 3 10 6 cells/ ml).
The assay was performed in 96-well low-volume plates certified for homogenous time-resolved fluorescence assays (Cisbio, Bedford, MA, USA). The assay was run in triplicate, and isobutylmethylxanthine was purchased from Sigma-Aldrich (I5879). Forskolin was used as positive control (F6886;
Sigma-Aldrich). The assay was performed according to manufacturer's protocol (62 AM4PEB; Cisbio), and the measurements were taken with a homogenous time-resolved fluorescence-compatible time-resolved fluorescence resonance energy transfer reader synergy neo plate reader (US Bio-Tek, Shoreline, WA, USA). Calculations of the ratio of the acceptor and donor emission signals for each individual well were calculated by the ratio of 665/ 620-nm and expressed as the fold change over vehicle.
CRF and Ucn assays in BMMCs
WT BMMCs were sensitized overnight at 37°C with 1 mg/ml anti-DNP-IgE in serum-free BMMC culture media. The following day, BMMCs (3 3 10 6 cells/ ml) were washed and seeded on a 24-well plate (0.5 ml/well) equilibrated in serum-free BMMC culture medium for 1 h and then stimulated with vehicle (serum-free medium), DNP (50 ng/ml), or A23187 (1 mM) for 0, 5, 15, 30, 45, and 60 min at 37°C. Cells were centrifuged, and supernatant was collected. Samples were run in duplicates, and neuropeptide (CRF and Ucn) concentrations in the supernatant were quantified with CRF and Ucn EIA kit (Phoenix Pharmaceuticals, Burlingame, CA, USA), respectively, according to the manufacturer's protocol.
Statistical analysis
Values are reported as means 6 SE based on the experimental number (n). Time-course data (body temperature and Ca 2+ responses) were analyzed using a 1-way ANOVA on repeated measures, with time and experimental group as the main factors. Comparison among multiple experimental groups was performed using a 1-or 2-way ANOVA, where appropriate, with a Tukey's posttest. Comparisons between two treatments were analyzed using an unpaired 2-tailed t test. Values of P , 0.05 were considered statistically significant. All statistical analyses and calculations were performed using Prism 5 software (GraphPad Software, San Diego, CA, USA).
RESULTS
CRF 1 antagonism attenuates in vivo IgE-mediated MC degranulation and anaphylaxis
To determine the biologic importance of CRF 1 in MC activation and MC-dependent pathophysiology in vivo, we examined that effect of prophylactic treatment with the CRF 1 antagonist antalarmin before induction of PSA. Overnight sensitization of mice with anti-DNP IgE, followed by DNP injection, induced a marked anaphylactic response in mice as determined by a 12-fold increase in serum histamine over control animals ( Fig. 1A) and a sharp reduction in core body temperature that was most severe at 30 min after DNP injection (2D5.4 6 0.29°C; Fig. 1B ).
Compared with IgE/DNP controls, mice prophylactically treated with antalarmin markedly attenuated PSA-induced serum histamine levels (by 65%) and hypothermia (by 56% (Fig. 2D) . Compared with WT C57Bl/6 mice used in the experiment described in Fig.  1 (Fig. 2E) .
CRF 1 agonists do not induce MC degranulation in murine BMMCs and RBL-2H3 MCs
Previous in vitro studies demonstrated that human MCs express CRF receptors, which, upon activation with CRF ligand, induce the release of de novo, synthesized mediators such as vascular endothelial growth factor, IL-6 IL8, and TNF [21, 22, 24] . Although these studies demonstrated the presence of functional CRF receptor signaling in MCs, the precise role of CRF receptor subtypes in MC degranulation remains to be fully elucidated. To address that gap in knowledge, we measured MC degranulation responses to CRF 1 agonists CRF and stressin 1 -A [34] in primary and transformed MC lines. First, we confirmed CRF receptor expression in commonly used rodent MC models, rat RBL-2H3 MCs, and murine BMMCs, via immunofluorescence labeling (Fig. 3A) and via quantitative PCR and/or Western blotting (Supplemental Fig. 1 ). Stimulation of MCs with CRF 1 ligands induced elevations in cAMP and pERK expression in BMMCs, thus confirming that CRF receptors on BMMCs were functional and induced canonical GPCR signaling ( Fig. 3B and C) . However, CRF 1 agonists failed to induce MC degranulation measured as b-hex release (Fig. 3D-F) . The range of concentrations used for CRF were based on the affinity of CRF for CRF 1 and CRF 2 [35, 36] and the ranges used previously in cultured MCs [22, 24, 37] and in tissue physiology experiments in humans and animals [38, 39] .
CRF 1 acts as a positive modulator of MC degranulation stimuli
The CRF 1 agonist experiments suggested that CRF 1 alone was insufficient to induce MC degranulation in vitro. Therefore, we next investigated whether CRF 1 could modulate MC degranulation induced by other MC degranulation stimuli. WT and CRF 1 2/2 BMMCs (derived from CRF 1 2/2 mice) were sensitized overnight with IgE-anti-DNP, followed by DNP to induce degranulation. Compared with WT BMMCs, CRF 1 2/2 BMMCs exhibited suppressed degranulation responses, measured as b-hex and histamine release ( Fig. 4A and B) . To determine whether the dampened degranulation responses in CRF 1
2/2
BMMCs were specific to IgE-FceR1-mediated signaling pathways, WT and CRF 1 2/2 BMMCs were also stimulated with MC stimuli, which use IgE-independent pathways to induce MC degranulation, including the Ca 2+ ionophore A23187 and the Mrgprb2 GPCR agonist c48/80 [40] . These experiments demonstrated a suppressed b-hex release in CRF 1 2/2 BMMCs after c48/80 and A23187 stimulation ( Fig. 4C and D) . Transmission electron microscopy confirmed degranulation responses, with CRF 1 2/2 BMMCs exhibiting a less-activated appearance compared with WT BMMCs upon IgE/DNP stimulation (Fig. 4E ). WT and CRF 1 2/2 BMMCs were shown to contain similar levels of b-hex in cell pellets and were phenotypically similar to WT BMMCs, as determined by toluidine blue staining and expression of c-kit and FceR1 by flow cytometry (Supplemental Fig. 1 ). Furthermore, we confirmed the reduced expression of CRF 1 in CRF 1 2/2 BMMCs and confirmed that CRF 1 deficiency did not significantly alter the expression of the other CRF receptor subtype, CRF 2 (Supplemental Fig. 1 ). Together these data provide support for attenuated degranulation responses observed in CRF 1
BMMCs not resulting from reduced intracellular mediator content or aberrant phenotype of BMMCs. Experiments conducted with human LAD2 MCs and rat RBL-2H3 MCs treated with dose concentrations of antalarmin showed similar results to genetic CRF 1 2/2 deficiency, with a dose-dependent suppression of IgE-mediated b-hex release ( Fig. 4F and G) . In contrast, costimulation of IgE/DNP with CRF (100 nM) enhanced b-hex release (Fig. 4H ).
To further define the role of CRF 1 expression as a modulator of MC degranulation, CRF 1 expression was stably and transiently knocked down in RBL-2H3 MCs with CRF 1 -shRNA and CRF 1 -siRNA approaches. RBL-2H3 cells were also transfected with CRF 1 overexpressing plasmid to enhance CRF 1 expression. These experiments showed that knockdown of CRF 1 with shRNA and siRNA resulted in the attenuation of IgE-FceR1-evoked b-hex ( Fig. 5A and B) and histamine release (Fig. 5C) , whereas, in contrast, CRF 1 overexpression in RBL-2H3 MCs amplified the degranulation response ( Fig. 5D and E) . We confirmed that CRF 1 -shRNA down-regulated CRF 1 protein expression by 42% in RBL-2H3 MCs by Western blot analyses (Fig. 5F) . Specifically, the CRF 1 Ab used recognized 2 major protein bands in RBL-2H3 MCs at ;55 and 37 kDa, which are consistent with the unprocessed form (55 kDa) and the deglycosylated form (37 kDa) of the receptor [41] and with previous reports by our group in the porcine intestine [18] and by others in the rodent intestine [42, 43] . In addition, we confirmed that lentiviralmediated CRF 1 overexpression resulted in a 76% increase in BMMCs store and rapidly release CRF and Ucn in a CRF 1 
-dependant manner
Because the effects of CRF 1 -expression cultured MCs were observed in the absence of exogenous CRF ligands, we hypothesized that MC CRF 1 activation and signaling during degranulation could be mediated by endogenous CRF 1 ligands. We, therefore, measured the expression and release of CRF 1/2 ligands CRF and Ucn under basal (nonstimulated) and IgEstimulated conditions in mouse BMMCs (Fig. 6) . These experiments showed that BMMCs store CRF and Ucn protein, as measured in cell pellets ( Fig. 6A and B) , and that CRF and Ucn are present in the supernatant from unstimulated BMMC cultures ( Fig. 6C and D) . Furthermore, upon stimulation with IgE/DNP in BMMCs, elevated concentrations of CRF and Ucn were detected in the supernatant within 2-5 min of DNP stimulation and reached peak values at 5 min, followed by a rapid decline in WT BMMCs (Fig. 6C and D BMMCs and then at 12 wk after engraftment, engrafted mice were subjected to acute RS. Compared with nonstressed controls, WT BMMC-engrafted Kit W-sh/W-sh mice exhibited a significant increase in serum histamine (by 1.6-fold; Fig. 7A ). In contrast, RS-induced histamine responses were absent in CRF 1 2/2 BMMCengrafted Kit W-sh/W-sh mice. Release of MC mediators, including proteases, TNF-a, and histamine have been shown to increase intestinal permeability [39, 44] , which is a central pathophysiologic mechanism in GI diseases, such as IBS and IBD [45] [46] [47] [48] . The in vitro and in vivo experiments in the present study collectively demonstrated an essential role for CRF 1 on MCs in amplifying MC degranulation responses. We next explored how CRF 1 positively modulated MC degranulation. Given that CRF 1 was shown to potentiate MC degranulation triggered by various upstream, receptor-dependent stimuli (IgE-FceR1 cross-linking and GPCR-triggered c48/80) and receptor-independent pathways (e.g., A23187), we hypothesized that CRF 1 was modulating a common downstream target in MC degranulation. It is well established that elevations in intracellular cytosolic Ca 2+ concentrations from release of intracellular stores and entry via store-operated Ca 2+ entry membrane channels is a central mechanism mediating MC granule exocytosis and mediator release [49] . Using Fura-2 Ca 2+ fluorescence imaging in BMMCs, we showed that CRF 1 2/2 BMMCs exhibited attenuated intracellular Ca 2+ mobilization in response to IgE/DNP, c48/80, and A23187 (Fig. 8A-C) . Ca 2+ responses were also diminished in RBL-2H3 MCs in which CRF 1 expression was knocked down with siRNA (Fig. 8D) or shRNA (Fig. 8E) , whereas, in contrast, CRF 1 -overexpressing RBL-2H3 MCs exhibited exacerbated IgE/DNPinduced by Ca 2+ mobilization (Fig. 8F) Data were analyzed using either a t test (A and B) or 2-way ANOVA (C and D) with a post hoc Tukey's test. *P , 0.05; **P , 0.001; ***P , 0.0001; ****P , 0.00001; * # P , 0.05 vs. other treatment groups (ANOVA). ( Fig. 9) , therefore, suggesting that CRF 1 potentiates Ca 2+ release from intracellular stores.
DISCUSSION
MCs play a critical role in host defense and are among the earliest immune cell responders to environmental, immunologic, and infectious stressors [2, 50] . To perform that role, MCs express a myriad of receptors to sense and integrate stress cues from the microenvironment and, in turn, elicit a quick and powerful immune response via degranulation. Stress is known to modulate MC degranulation and exacerbate MC-associated disorders [5, 7, 51] . Although many stress mediators, such as CRF substance P and catecholamines, have been shown to influence MC activity, the precise mechanisms by which stress modulates MC degranulation and disease susceptibility in vivo has remained elusive. Using genetic and pharmacologic approaches in culture of rodent and human MCs and MC-dependent animal models of anaphylaxis and psychologic stress, we demonstrated a novel role for the MC CRF system via CRF 1 receptors in the potentiation of MC degranulation responses and downstream disease pathophysiology.
In the present study, prophylactic administration of the CRF 1 -antagonist antalarmin significantly attenuated IgE-mediated MC degranulation and anaphylaxis, thus demonstrating the importance of CRF 1 [22, 24] . However, a compound exocytosis/endocytosis event and 5HT release induced by CRF has been described previously in mouse peritoneal and intestinal MCs [37] . The lack of degranulation response in the present study suggests that the GPCR signaling pathways induced upon CRF 1 activation may not directly trigger significant MC degranulation; however, the possibility that in vitro conditions or in vivo tissue factors have a role cannot be ruled out. Despite the inability of CRF 1 activation to induce MC degranulation, we showed that activation or inhibition of CRF 1 via genetic and pharmacologic approaches resulted in an enhancement or attenuation of stimuli-induced MC degranulation, respectively, induced by a broad array of potent MC stimuli, including IgE/ FcƐR1 cross-linking, c48/80, and A23187. These findings were Data were analyzed using a t test *P , 0.05; **P , 0.001; ***P , 0.0001. In the present study, CRF 1 expression or pharmacologic blockade in MCs was able to modulate stimuli-induced MC degranulation in the absence of exogenous CRF 1 ligands. Experiments measuring the cellular content and the time course release of CRF and Ucn in activated BMMCs revealed that CRF and Ucn are both stored as proteins in the MC and are constitutively released under basal conditions. Furthermore, upon activation with IgE/DNP, a rapid release of CRF and Ucn was observed, which was measurable within 2 min of stimulation, peaked at 5 min, and then rapidly declined thereafter. Together these data provide evidence under basal and activated conditions that CRF receptors are continually exposed active ligands, which conceivably, can rapidly modulate responses to MC stimuli in an autocrine manner. The reason for the decline in supernatant levels of CRF and Ucn after 5 min of stimulation is unclear at this time but could represent a rapid reuptake or retrieval of CRF and Ucn by MCs. Released granule mediator recycling is known to occur rapidly after induction of exocytosis in MCs [52] . Interestingly, we found that CRF Precisely how initiation of upstream CRF 1 signaling leads to a potentiation of stimuli-induced intracellular Ca 2+ release and degranulation remains to be elucidated. CRF 1 and CRF 2 receptors are class B1 (secretin-like) GPCRs with complex signaling mechanisms that can couple to different G proteins in a cell-type-specific manner to produce an array of downstream signaling. Although both receptors are reported to activate Gas and cAMP signaling and Gq and Ca 2+ signaling [56, 57] , there is also clear evidence for coupling to Gq/11 and Gi/o proteins [30, [58] [59] [60] . The latter 2 contribute to activating ERK [58, 61] . The downstream effector mechanisms of CRF 1 and CRF 2 receptors may also be modulated by cell-type and/or coexpressed scaffolding proteins [30, 60, 61] . GPCRs, such as EP-and sphingosine 1 phosphate-adenosine receptors, can modulate IgE antigen-mediated Ca 2+ mobilization and degranulation via G protein-dependent mechanisms [62] [63] [64] [65] [66] [67] [68] [69] . It remains unclear whether CRF 1 uses similar mechanisms. Given that Ca 2+ mobilization represents a common downstream mechanism for degranulation induced by many MC stimuli, these findings implicate a likely mechanism by which CRF 1 exerts a global influence on MC degranulation in response to broad range of MC stimuli. [10, 38, 39] , the precise mechanisms have remained controversial. This new finding has implications for the understanding of highly prevalent GI conditions associated with impaired intestinal barrier function, such as IBS and IBD. The broad potentiating influence of CRF 1 in response to various MC stimuli and in different disease models demonstrated in the present study could provide unique insight into a common pathogenesis for a wide range of MC disorders in which disease flares are triggered by stress, including IBS, chronic pain disorders, arthritis, and asthma. For example, dysregulation of a common stress pathway in the MC, potentially via the MC-CRF 1 system, could result in an overall hyperreactive MC state, which, in turn, would lead to exacerbated MC responses and disease. Although such a system may have evolved as a protective mechanism to up-regulate MC activity and host defense in the face of an acute, stressful challenge, dysregulation of this system could contribute to chronic MC disease through the persistent, heightened MC activity. Further elucidation of the mechanisms by which CRF 1 amplifies MC responses and under which disease states (e.g., acute vs. chronic, psychologic vs. infections, etc.) will be important to identify potential downstream targets aimed at suppressing MC degranulation and disease. Alternatively, knowledge of how CRF 1 enhances MC function could also be applied to situations in which augmenting MC responses would be beneficial to the host, such as for the clearance of pathogens [70, 71] or as vaccine adjuvants [72, 73] .
In summary, the present study highlights a novel role for CRF 1 receptors expressed on MCs as positive, global modulators of MC degranulation in the acute responses to immunologic and psychologic stress. Given the critical role of MCs as immune sentinels that rapidly respond to diverse stressful stimuli, the MC CRF system may represent a sensing mechanism by the MC to integrate environmental and host stress cues and rapidly amplify degranulation responses, which are critical for survival and the return to homeostasis. However, at the same time, dysregulation or chronic activation of this system could also contribute to mechanisms of chronic disease.
